JP2024542015A5 - - Google Patents

Info

Publication number
JP2024542015A5
JP2024542015A5 JP2024525582A JP2024525582A JP2024542015A5 JP 2024542015 A5 JP2024542015 A5 JP 2024542015A5 JP 2024525582 A JP2024525582 A JP 2024525582A JP 2024525582 A JP2024525582 A JP 2024525582A JP 2024542015 A5 JP2024542015 A5 JP 2024542015A5
Authority
JP
Japan
Prior art keywords
tcf7l2
host cell
glial progenitor
gene construct
cell according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525582A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024542015A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079028 external-priority patent/WO2023081633A1/en
Publication of JP2024542015A publication Critical patent/JP2024542015A/ja
Publication of JP2024542015A5 publication Critical patent/JP2024542015A5/ja
Pending legal-status Critical Current

Links

JP2024525582A 2021-11-02 2022-11-01 脳内でのtcf7l2媒介性髄鞘再生 Pending JP2024542015A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163274763P 2021-11-02 2021-11-02
US63/274,763 2021-11-02
US202263378092P 2022-10-03 2022-10-03
US63/378,092 2022-10-03
PCT/US2022/079028 WO2023081633A1 (en) 2021-11-02 2022-11-01 Tcf7l2 mediated remyelination in the brain

Publications (2)

Publication Number Publication Date
JP2024542015A JP2024542015A (ja) 2024-11-13
JP2024542015A5 true JP2024542015A5 (cg-RX-API-DMAC7.html) 2025-10-22

Family

ID=84569688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525582A Pending JP2024542015A (ja) 2021-11-02 2022-11-01 脳内でのtcf7l2媒介性髄鞘再生

Country Status (5)

Country Link
US (1) US20230270818A1 (cg-RX-API-DMAC7.html)
EP (1) EP4426331A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024542015A (cg-RX-API-DMAC7.html)
CA (1) CA3236365A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023081633A1 (cg-RX-API-DMAC7.html)

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650764A (en) 1983-04-12 1987-03-17 Wisconsin Alumni Research Foundation Helper cell
US5059421A (en) 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
US4980289A (en) 1987-04-27 1990-12-25 Wisconsin Alumni Research Foundation Promoter deficient retroviral vector
US5082670A (en) 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5124263A (en) 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
US5328470A (en) 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
US6497872B1 (en) 1991-07-08 2002-12-24 Neurospheres Holdings Ltd. Neural transplantation using proliferated multipotent neural stem cells and their progeny
US5350674A (en) 1992-09-04 1994-09-27 Becton, Dickinson And Company Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
EP0673431A1 (en) 1992-12-03 1995-09-27 Genzyme Corporation Gene therapy for cystic fibrosis
US5631237A (en) 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
FR2705361B1 (fr) 1993-05-18 1995-08-04 Centre Nat Rech Scient Vecteurs viraux et utilisation en thérapie génique.
FR2705686B1 (fr) 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
CA2163860A1 (en) 1993-06-30 1995-01-12 Chung C. Hsu Method for preparing liposomes
CA2144040A1 (fr) 1993-07-13 1995-01-26 Michel Perricaudet Vecteurs adenoviraux defectifs et utilisation en therapie genique
US5885613A (en) 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US5643599A (en) 1995-06-07 1997-07-01 President And Fellows Of Harvard College Intracellular delivery of macromolecules
AU4645697A (en) 1996-09-11 1998-04-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Aav4 vector and uses thereof
US6245564B1 (en) 1997-01-23 2001-06-12 Cornell Research Foundation, Inc. Method for separating cells
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
DE69939169D1 (de) 1998-05-28 2008-09-04 Us Gov Health & Human Serv Aav5 vektoren und deren verwendung
DE69936104T2 (de) 1998-11-05 2008-01-17 The Trustees Of The University Of Pennsylvania Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten
EP1135468B1 (en) 1998-11-10 2010-01-06 University Of North Carolina At Chapel Hill Virus vectors and methods of making and administering the same
EP1235842A4 (en) 1999-10-15 2003-04-23 Univ Massachusetts Rna interference pathway genes as tools for targeted genetic interference
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
US7465583B2 (en) 2000-06-01 2008-12-16 The University Of North Carolina At Chapel Hill Duplexed parvovirus vectors
WO2001096584A2 (en) 2000-06-12 2001-12-20 Akkadix Corporation Materials and methods for the control of nematodes
US20030223972A1 (en) 2002-02-15 2003-12-04 Goldman Steven A. Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
US20040029269A1 (en) 2002-05-07 2004-02-12 Goldman Steven A Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
JP4428296B2 (ja) 2005-06-10 2010-03-10 セイコーエプソン株式会社 表示パネルモジュールおよび表示装置
US20100215724A1 (en) 2005-11-22 2010-08-26 Mcgill University Microcapsule Nanotube Devices for Targeted Delivery of Therapeutic Molecules
EP2206724A1 (en) 2005-12-13 2010-07-14 Kyoto University Nuclear reprogramming factor
DK2114167T3 (en) 2007-01-16 2018-09-17 Univ Rochester NON-HUMAN ANIMALS WITH HUMAN GLIAKIMARY BRAIN
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
EP2315829B1 (en) 2008-08-08 2015-02-11 Mayo Foundation For Medical Education And Research Induced pluripotent stem cells
WO2010045659A1 (en) 2008-10-17 2010-04-22 American Gene Technologies International Inc. Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
WO2011062963A2 (en) 2009-11-17 2011-05-26 Vitro Diagnositics, Inc. Induced puripotent stem cells and related methods
US9005967B2 (en) 2010-01-22 2015-04-14 Kyoto University Myc variants improve induced pluripotent stem cell generation efficiency
EP2771455B1 (en) 2011-10-28 2016-10-05 The University of North Carolina At Chapel Hill Cell line for production of adeno-associated virus
PL2900686T3 (pl) 2012-09-28 2021-01-25 The University Of North Carolina At Chapel Hill Wektory aav ukierunkowane na oligodendrocyty
EP3766962B1 (en) 2013-02-06 2025-10-22 University of Rochester Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders
US11136557B2 (en) 2013-05-31 2021-10-05 The Regents Of The University Of California Adeno-associated virus variants and methods of use thereof
NZ716102A (en) 2013-07-22 2021-12-24 The Children’S Hospital Of Philadelphia Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues
GB201403684D0 (en) 2014-03-03 2014-04-16 King S College London Vector
EP4378487A3 (en) 2015-06-23 2024-09-04 The Children's Hospital of Philadelphia Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
SI3710067T1 (sl) 2017-11-14 2026-01-30 Arcellx, Inc. Polipeptidi, ki vsebujejo D-domeno, in njihova uporaba
BR112020016570A2 (pt) 2018-02-17 2020-12-15 Flagship Pioneering Innovations V, Inc. Composições e métodos para liberação de proteína de membrana
US12303549B2 (en) * 2018-06-21 2025-05-20 University Of Rochester Methods of treating or inhibiting onset of Huntington's disease
CA3105953A1 (en) 2018-07-09 2020-01-16 Flagship Pioneering Innovations V, Inc. Fusosome compositions and uses thereof
EP3923962A2 (en) * 2019-02-13 2021-12-22 University of Rochester Gene networks that mediate remyelination of the human brain
CN115461066B (zh) 2020-04-28 2026-01-06 美国辉瑞有限公司 用于基因疗法的编码天冬氨酸酰化酶(aspa)的经修饰的核酸和载体

Similar Documents

Publication Publication Date Title
JP2023525810A5 (cg-RX-API-DMAC7.html)
Hutson et al. Corticospinal tract transduction: a comparison of seven adeno-associated viral vector serotypes and a non-integrating lentiviral vector
JP2021512649A (ja) 転写調節要素及びその使用
Siu et al. Improved gene delivery to adult mouse spinal cord through the use of engineered hybrid adeno-associated viral serotypes
AU2021209012A1 (en) Nucleic acid loaded red blood cell extracellular vesicles
JP2023535620A (ja) 組成物および方法
BR112020020841A2 (pt) Composições e métodos para transplante de célulastronco
Hoshino et al. The adeno-associated virus rh10 vector is an effective gene transfer system for chronic spinal cord injury
Serrano et al. Simple and highly specific targeting of resident microglia with adeno-associated virus
Nouraein et al. Acoustically targeted noninvasive gene therapy in large brain volumes
JP7334996B2 (ja) グルコーストランスポーター1発現用アデノ随伴ウイルスベクター
Yu et al. Lentiviral gene transfer into the dorsal root ganglion of adult rats
O’Connor et al. Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy
WO2023288086A2 (en) Enhancers driving expression in motor neurons
JP2024507732A (ja) ハイッブリッドaav-アネロベクター
JP2024539080A5 (cg-RX-API-DMAC7.html)
JP2025502746A (ja) ポリペプチド、核酸構造物とベクトルおよびこれらを使用する疾患の治療方法、予防方法および緩和方法
JP7680072B2 (ja) リプログラミング用機能性断片、組み合わせ、およびその用途
TWI877887B (zh) 轉運胜肽及其應用
JP2024500115A5 (cg-RX-API-DMAC7.html)
O'connor Introduction to gene and stem-cell therapy
CN121358754A (zh) 具有外周器官去靶向性的新型嗜神经性腺相关病毒衣壳
Galvan et al. MiniPromoters Ple384 (TH) and Ple388 (PITX3) for targeting midbrain dopaminergic neurons in mice and monkeys
Wang et al. LRP6-Guided Engineering of AAV9 Variants with Enhanced Blood-Brain Barrier Penetration and Reduced Liver Tropism in Non-Human Primates
Nandi et al. Revolutionizing Gene Therapy: An Explicative Review on Engineering Adeno-associated Virus Vectors